Spire Wealth Management A Ikido Pharma Inc. Transaction History
Spire Wealth Management
- $2.7 Billion
- Q2 2025
A detailed history of Spire Wealth Management transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Spire Wealth Management holds 557 shares of AIKI stock, worth $2,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
557Holding current value
$2,116% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AIKI
# of Institutions
24Shares Held
680KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA189KShares$717,9300.0% of portfolio
-
Exodus Point Capital Management, LP New York, NY110KShares$418,0000.0% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.3KShares$251,8750.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny52.3KShares$198,6030.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...